ReviewCureus2025
A Narrative Review of Tuberculosis and Diabetes Mellitus: The Double Burden Epidemiology, the Current Moment and the Future.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis and diabetes are major global health concerns, with their prevalences projected to increase disproportionately in the low- and middle-income countries (LMICs). The convergence of tuberculosis and diabetes impact is also expected to rise, posing a negative synergism that complicates disease management and outcomes. This review aims to summarise tuberculosis and diabetes double burden epidemiology, the overlap, the current moment and future prospects, including exploration of cost-effective interventions to enhance tuberculosis and diabetes integrated care. A literature search was conducted in PubMed, Embase, African Journals Online and Google Scholar on January 1, 2025, to identify studies published between January 1, 2020, and December 1, 2024, on the double burden of tuberculosis and diabetes, as well as integration models. There were no language restrictions. The diagnostic criteria for tuberculosis and diabetes, as well as the integration models, were aligned with WHO guidelines. After screening abstracts and full texts, 35 articles were included in this review. The double burden of tuberculosis and diabetes presents unique challenges at present, but unlocking potential for new opportunities to transform global healthcare delivery amid the increasing double burden disease phenomenon. Integrating tuberculosis and diabetes care is essential to avoid further strain on the already fragile healthcare delivery systems in LMICs. Integrated care enhances bi-directional screening, promotes a holistic approach of treatment and management, and optimises outcomes for both diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.